CLPP and neoplasm: These findings indicate that disruption of HSP60-ClpP interactions by DCEM1 inhibits PCa cell survival and tumor growth by deregulating mitochondrial proteostasis, aggravating the generation of mitoROS, and inhibiting key PCa cell survival pathways.